NCT06908109

Brief Summary

The aim of this study is to evaluate the effectiveness of a simple intervention through a classical Yankauer oral suction tube, a device known to have a proven safety profile in multiple healthcare settings, in decreasing the sedative and opioid medication doses needed to provide effective patient sedation during bronchoscopy, along with its effect on both patient's and bronchscopist's satisfaction throughout the procedure.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2016

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 4, 2016

Completed
6.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 14, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 14, 2022

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

March 21, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 3, 2025

Completed
Last Updated

April 4, 2025

Status Verified

April 1, 2025

Enrollment Period

6.6 years

First QC Date

March 21, 2025

Last Update Submit

April 2, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean doses of Midazolam and Fentanyl

    From the time of enrollment (pre-bronchoscopy) to the end of the bronchoscopic procedure

    From enrollment (pre-bronchoscopy) to the end of the bronchoscopic procedure (up to 30 minutes)

Study Arms (2)

Sham Group

SHAM COMPARATOR

The control group: included another 60 patients, who underwent the regular FB procedure with a blinded defective Yankauer suction device (Sham) attached to the oral cavity of the patient and present throughout the procedure.

Procedure: Bronchoscopy

Yankauer group

ACTIVE COMPARATOR

The intervention group: included 60 patients, who underwent the regular FB procedure with a functional standard Yankauer suction device attached to the oral cavity of the patient and present throughout all the procedure.

Device: Yankauer Suction DeviceProcedure: Bronchoscopy

Interventions

The Yankauer suction device is a hollow, curved and flexible tube that has a suction tip surrounded by a bulbous head to allow effective suctioning without damaging the surrounding tissue. It has been frequently used in multiple settings that range from minor dental procedures to large surgeries. It is also frequently used in the intensive care units to suction oropharyngeal secretions and prevent aspiration. Throughout this study, and regardless of the study group (control or intervention group), the Yankauer suction device is attached to a distinct suction port and placed, at the other end, inside the oral cavity of the patient.

Yankauer group
BronchoscopyPROCEDURE

Flexible bronchoscopy done for the following indications: presence of a lung mass or collapse, persistent pulmonary infiltrates, pulmonary infection in the setting of immunosuppression, hemoptysis, or other rare causes like chronic cough. Flexible bronchoscopy (FB) is a medical procedure that has been used for more than five decades for the diagnostic evaluation and/or therapeutic intervention in a multitude of pulmonary and bronchial diseases

Sham GroupYankauer group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or above
  • inpatients or outpatients
  • scheduled to have a flexible bronchoscopy for one of multiple indications based on their physician's assessment, including the presence of a lung mass or collapse, persistent pulmonary infiltrates, pulmonary infection in the setting of immunosuppression, hemoptysis, or other rare causes like chronic cough.
  • patients provided a written informed consent.

You may not qualify if:

  • patients with anatomic oro-pharyngeal abnormalities,
  • critically ill patients
  • uncooperative patients or inability to provide signed consent by the patient or their legal representative
  • coagulopathy or bleeding diathesis
  • severe obstructive airway disease
  • recent myocardial infarction
  • uncontrolled or poorly controlled asthma or chronic obstructive pulmonary disease (COPD)
  • pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Bronchoscopy

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Respiratory SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalMinimally Invasive Surgical ProceduresSurgical Procedures, OperativePulmonary Surgical ProceduresThoracic Surgical Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate

Study Record Dates

First Submitted

March 21, 2025

First Posted

April 3, 2025

Study Start

March 4, 2016

Primary Completion

October 14, 2022

Study Completion

October 14, 2022

Last Updated

April 4, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share